Merck & Co. paid its 5 named executives $48.5M in total in FY2025 (Dec). CEO Robert M. Davis was paid $20.8M of that.
PayNo stock prices for these years
Pay of each named executive
Robert M. DavisChairman, Chief Executive Officer and President
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Dean Li, M.D., Ph.D.Executive Vice President and President, Merck Research Laboratories
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Caroline LitchfieldExecutive Vice President and Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Jennifer ZacharyExecutive Vice President and General Counsel
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Sanat ChattopadhyayExecutive Vice President and President, Merck Manufacturing Division
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $28.0M. The CEO of Merck & Co. was paid $20.8M, 26% below the median.
- 1Johnson & Johnson
- 2AbbVie
- 3Gilead Sciences
- 4Pfizer
- 5Amgen
- 6Bristol Myers Squibb
- 7Merck & Co.This company
- 8AstraZenecaNot disclosed
- 9Eli LillyNot disclosed
- 10GlaxoSmithKlineNot disclosed
- 11NovartisNot disclosed
- 12Roche Holding AGNot disclosed
- 13SanofiNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.